Improvement of positive and negative syndrome scale cognitive score associated with olanzapine treatment of acute mania

Current Medical Research and Opinion

Volumn 20, Issue 9, 2004, Pages 1371-1376

  Shi, Lizheng ^a   Schuh, Leslie M ^a   Trzepacz, Paula T ^a,b,c   Huang, Linda X ^a   Namjoshi, Madhav A ^a   Tohen, Mauricio ^a,d  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; Cognition; Mania; Olanzapine; PANSS

Indexed keywords

OLANZAPINE; PLACEBO;

ADULT; ANALYSIS; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON SCALE; HUMAN; LAST OBSERVATION CARRIED FORWARD METHOD; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD DISORDER; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; POOLED ANALYSIS; POSITIVE AND NEGATIVE SYMPTOM SCALE COGNITIVE SCORE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; THOUGHT DISORDER; YOUNG MANIA RATING SCALE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; COGNITION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS;

EID: 5444274745     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125004493     Document Type: Article

References (24)

1. Stip E, Dufresne J, Lussier I, Yatham L. A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning. J Affect Dis 2000;60(3):147-57
2. Reinares M, Martinez-Aran A, Colom F, Benabarre A, Salamero M, Vieta E. Long-term effects of the treatment with risperidone versus conventional neuroleptics on the neuropsychological performance of euthymic bipolar patients. Actas Espanolas de Psiquiatria 2000;28(4):231-8
3. Yurgelun-Todd D, Shi L, Zhu B, et al. Olanzapine versus divalproex: prospective comparison on self-reported cognitive function in patients with bipolar disorder. Eur Neuropsychopharm 2002;12(S3):S308
4. Lindenmayer JP, Volavka J, Lieberman J, et al. Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial. J Clin. Psychopharm 2001;21(4):448-53
5. Kay SR, Sevy S. Pyramidal model of schizophrenia. Schizophr Bull 1990;16:537-45
6. Lepine J, Prion J, Chapatot E. Factor analysis of the PANSS in schizophrenia. In: Stefanis C, Soldatos C, Rabavilas A, editors. Psychiatry today: accomplishment and promises. Almere: Excerpta Medica, 1990
7. Bell MD, Lysaker PH, Beam-Goulet JL, Milstein RM, Lindenmayer JP. Five-compartment model of schizophrenia: assessing the factorial variance of the positive and negative syndrome scale. Psychiatry Res 1994a;52:295-303
8. Bell MD, Lysaker PH, Milstein RM, Beam-Goulet JL. Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments. Psychiatry Res 1994b;54:51-8
9. White L, Parrella M, Harvey P, Powchik P, Davidson M. PANSS structure in adult and geriatric schizophrenia. 145th Annual Meeting of the American Psychiatric Association, Washington (DC): 1992 [Symposium]
10. Lindenmayer JP, Grochowski S, Hyman RB. Five factor model of schizophrenia: replication across samples. Schizophr Res 1995;14:229-34
11. Lancon C, Auquier P, Nayt G, Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res 2000;42(3):231-9
12. Lindenmayer JP, Brown E, Baker RW, et al. A mania-like symptom subscale from the Positive and Negative Syndrome Scale. Schizophr Res 2004;68:331-7
13. Daneluzzo E, Arduini L, Rinaldi O, et al. PANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive component. Schizophr Res 2002;56(1-2):129-36
14. Tohen M, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999;156:702-9
15. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000;57:841-9
16. Baldessarini RJ, Hennen J, Wilson M, et al. Olanzapine vs. placebo in acute mania: reanalysis of pooled data from controlled trials. Am J Psychiatry [in press]
17. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for the diagnostic and statistical manual, 4th ed. Patient version. Washington (DC): American Psychiatric Press; 1997
18. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-35.
19. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1967;23:56-62
20. Steel RGD, Torrie JH. Principles and procedures of statistics, 2nd ed. New York (NY): McGraw-Hill Book Company; 1980
21. SAS Institute Inc., 1990. SAS/STAT User's Guide. SAS Institute Inc, Gary (NC)
22. Baker RW, Tohen M, Fawcett J, et al. Acute dysphoric mania: treatment response to olanzapine compared to placebo. J Clin Psychopharm 2003;23(2):132-7
23. Van Gorp WG, Wilkins JN, Hinkin CH, et al. Declarative and procedural memory functioning in abstinent cocaine abusers. Arch Gen Psychiatry 1999;56(1):85-9
24. Carey KB, Carey MP, Simons JS. Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status. J Nervous & Mental Dis 2003;191(5):300-8